Skip to main navigation Skip to search Skip to main content

A 26-week, Multinational, Multi-centre, Open-Labelled, Randomised, Parallel, Efficacy and Safety Comparison of Insulin Degludec and Insulin Determir in children and adolescents 1 to less than 18 years with type 1 Diabetes Mellitus

Project: Research

Project Details

StatusFinished
Effective start/end date04/10/1204/10/14

Funding

  • Novo Nordisk Incorporated: $32,853.00